Tinnitus
Conditions
Interventions
Drug therapy group:Oral administration of Ginkgo biloba extract tablets
Sound combined with medication group:music
Sponsors
Shenzhen Second People's Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients with tinnitus frequency between 125 Hz and 8000 Hz; 2. Patients with chronic tinnitus (otolaryngology head and neck surgery 2014 tinnitus clinical guidelines: chronic tinnitus is defined as continuous tinnitus lasting more than 6 months at the time of examination); 3. Patients without tinnitus treatment; 4. Patients who did not take stimulants and ototoxic drugs; 5. Patients who are willing to follow up.
Exclusion criteria
Exclusion criteria: 1. Exclude pulsatile tinnitus; 2. Patients with a history of auditory trauma; 3. Patients with middle or inner ear diseases (such as otosclerosis, chronic suppurative otitis media or endolymphatic hydrops); 4. Severe hearing asymmetry between ears, patients with post cochlear lesions, tinnitus induced by previous ear surgery and other diseases; 5. Patients with head and neck discomfort or tinnitus caused by temporomandibular or cranial neck; 6. Have used or are using other oral drugs to improve microcirculation within 3 months; 7. Women who are pregnant or prepare for pregnancy within 12 months; 8. Patients with severe chronic diseases not under control.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| THI;SAS;EEG; | — |
Countries
China
Contacts
Public ContactHongsong Dong
Shenzhen Second People's Hospital
Outcome results
None listed